| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1988) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C08CA06 |
| UNII: | 57WA9QZ5WH |
| InChI Key | UIAGMCDKSXEBJQ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H26N2O7 |
| Molecular Weight | 418.45 |
| AlogP | 2.97 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 117.0 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 30.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Mineralocorticoid receptor antagonist | PubMed |
| Primary Target | |
|---|---|
| Mineralocorticoid receptor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Subarachnoid Hemorrhage | 3 | D013345 | ClinicalTrials |
| Neurilemmoma | 2 | D009442 | ClinicalTrials |
| Stroke | 2 | D020521 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Infertility | 2 | D007246 | ClinicalTrials |
| Intracranial Aneurysm | 1 | D002532 | ClinicalTrials |
| Schizophrenia | 0 | D012559 | ClinicalTrials |
| Cerebrovascular Disorders | 0 | D002561 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 66085-59-4 |
| ChEBI | 7575 |
| ChEMBL | CHEMBL1428 |
| DrugBank | DB00393 |
| DrugCentral | 1937 |
| EPA CompTox | DTXSID5023370 |
| FDA SRS | 57WA9QZ5WH |
| Human Metabolome Database | HMDB0014537 |
| Guide to Pharmacology | 2523 |
| KEGG | C07267 |
| PharmGKB | PA450633 |
| PubChem | 4497 |
| SureChEMBL | SCHEMBL34041 |
| ZINC | ZINC19632718 |